Home > Newsletters > International Pharmaceutical Regulatory Monitor > U.K. Report Recommends Overhaul of OTC Drug Regulation
International Pharmaceutical Regulatory Monitor
July 2006 | Vol. 34 No. 7
U.K. Report Recommends Overhaul of OTC Drug Regulation
Prioritizing changes to patient information on over-the-counter (OTC) medications could significantly ease the regulatory burden on both the OTC industry and regulators, concludes a recent report by the Better Regulation of OTC Medicines Initiative (BROMI), a public and private coalition led by the Medicines and Healthcare products Regulatory Agency (MHRA).
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.